Organization
Vectura Group Plc
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Vectura Group Plc
... full swing yesterday following the Christmas lull, speculating that asthma inhaler maker Vectura could be in the crosshairs of pharma giant GLAXOSMITHKLINE, looking to capitalise ...
... Chippenham, UK - Vectura Group plc (LSE: VEC) ('Vectura' or the 'Group'), an industry-leading device and formulation business ...
... ASTHMA inhaler maker Vectura yesterday managed to reverse a 5.6pc share price slide, after it earlier ...
... CITY chatter swirled around pharma company Vectura yesterday amid speculation that one of its partners such as Novartis could ...
... Chippenham, UK - Vectura Group plc (LSE: VEC) ('Vectura', 'the Group', 'the Company'), an industry leading device and ...
... VECTURA GROUP Vectura Group, an industry leading device and formulation business for inhaled ...
... Chippenham, UK - Vectura Group plc (LSE: VEC) ('Vectura'), an industry-leading device and formulation business for inhaled airways ...
... Chippenham, UK - Vectura Group plc (LSE: VEC) ('Vectura', 'the Group'), announces that the Board has approved a ...
... Those waiting for Hikma and Vectura’s copy of GlaxoSmithKline blockbuster Advair may be waiting awhile. After receiving a ...
... we made significant progress with our clinical stage programs. We partnered with Vectura to develop Pulmatrix's drug candidate, PUR0200, for chronic obstructive pulmonary disease (COPD) ...
... Previously, she was CFO of BBI Diagnostics Group Ltd and FTSE-listed Vectura Group plc. Prior to her role at Vectura, Anne held a number of ...
... FTSE 250 inhaler maker Vectura enjoyed a lift yesterday after its improved version of asthma medicine Flutiform ...
... huge impact on a person's quality of life and day-to-day activities. About Vectura Vectura, a FTSE250 company listed on the London Stock Exchange (LSE: VEC), ...
... SHARES in inhaler maker Vectura dropped as much as 14 per cent yesterday after the firm reported ...
... SHARES in FTSE 250 inhaler maker Vectura fell 12.9pc yesterday as the firm posted increased half-year losses. The group, ...
... pulmonary diseases, today announced that it has partnered withVecturaGroup plc (LSE: VEC) ("Vectura") to develop Pulmatrix's drug candidate, PUR0200, for chronic obstructive pulmonary disease (COPD) ...
... Chippenham, UK - Vectura Group plc (LSE: VEC) ('Vectura', 'the Group'), an industry leading device and formulation business ...
... Chippenham, UK - Vectura Group plc (LSE: VEC) ('Vectura'), an industry-leading device and formulation business for inhaled airways ...
... put together a €20 million financing round by July 2018. Statement > Vectura landed a deal with Dynavax. The agreement clears Dynavax to use Vectura’s ...
... VECTURA, the FTSE 250 maker of respiratory devices, yesterday announced an exclusive agreement ...
... sector. For more information about this report visit - Zelos Therapeutics - Vectura - United Therapeutics - UCB - Tianjin Kinnovata Pharmaceutial - Teva - ...
... Chippenham, UK - Vectura Group plc (LSE: VEC) ('Vectura', 'the Group'), an industry-leading device and formulation business for ...
... Vectura Group plc along with its co-development partner UCB SA has announced that they ...
... Chippenham, UK - Vectura Group plc (LSE: VEC) ('the Group'), an industry-leading inhaled airways disease focused business, will ...
Want to see the full history on Vectura Group Plc? Upgrade to RelSci Pro now!
Start My Free Trial